Last $37.35 USD
Change Today -0.28 / -0.74%
Volume 549.1K
MYGN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

S. Louise Phanstiel

Independent Director, Chairman of Audit Committee and Member of Nominating & Governance Committee, Myriad Genetics Inc.
AgeTotal Calculated CompensationThis person is connected to 29 board members in 2 different organizations across 2 different industries.

See Board Relationships
56$403,354

Background*

Ms. S. Louise Phanstiel served as a Partner of Coopers & Lybrand, LLP. At Coopers & Lybrand, Ms. Phanstiel served clients in life and property/casualty insurance, high technology, and higher education. She held several important positions at WellPoint, Inc. from 1996 to 2007, including President of Specialty Products from 2003 to 2007; Senior Vice President, Chief of Staff and Corporate Planning in the Office of the Chairman from 2000 to 2003; and Senior Vice President, ...

Read Full Background

Corporate Headquarters*

320 Wakara Way
Salt Lake City, Utah 84108

United States

Phone: 801-584-3600
Fax: 801-584-3640

Board Members Memberships*

2009-Present
Independent Director, Chairman of Audit Committee and Member of Nominating & Governance Committee
2012-Present
Director, Chairman of Audit Committee and Member of Governance & Nominating Committee

Education*

BA
Golden Gate University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options90,000
Unexercisable Options30,000
Total Number of Options120,000

Total Compensation*

Total Annual Cash Compensation$98,500
Total Calculated Compensation$403,354
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MYGN:US $37.35 USD -0.28

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marc D. Grodman M.D.Founder, Chairman, Chief Executive Officer, President and Managing Director
Bio-Reference Laboratories Inc.
$1.2M
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$557.0K
Russell Cummings Chief Executive Officer, Executive Director, and Member of Investment Committee
Imperial Innovations Group plc
210.0K GBP
Kimberly J. Popovits Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$600.0K
Michael J. Pellini M.D., MBAChief Executive Officer, President and Director
Foundation Medicine, Inc.
$403.9K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MYRIAD GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.